Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal
exposure to substances that were used or abused by the mother during pregnancy …

A central goal of The Academy of Breastfeeding Medicine is the development of clinical
protocols for managing common medical problems that may impact breastfeeding success …

Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Safety of maternal drug therapy during breastfeeding may be assessed from estimated
levels of drug exposure of the infant through milk. Pharmacokinetic (PK) principles predict …

Background: Infants with neonatal abstinence syndrome (NAS) experience withdrawal that
occurs as a result of termination of placental opioid supply following delivery. Common …

Objective To review the literature about the association between breastfeeding and neonatal
abstinence syndrome (NAS) severity, need for pharmacologic treatment for NAS, and length …

The use of substances of abuse in pregnancy creates significant barriers to receiving high-
quality prenatal, intrapartum, and postpartum care (Box 1). Yet clinicians who recognize and …

Background Despite evidence of low transfer of methadone into breast milk and the potential
physical and psychological benefits that breastfeeding offers for methadone-exposed …

Background: In addition to the well-known benefits of human milk and breastfeeding for the
mother and infant, breastfeeding may mitigate neonatal abstinence syndrome severity in …

Objectives We investigated the efficacy and safety of tacrolimus (TAC) by monitoring its
serum concentration for mothers and infants in pregnant patients with systemic lupus …